High-titer collapsin response-mediating protein-associated (CRMP-5) paraneoplastic optic neuropathy and Vitritis as the only clinical manifestations in a patient with small cell lung carcinoma.
暂无分享,去创建一个
[1] C. Vedeler,et al. Treatment of Paraneoplastic Neurological Syndromes , 2009 .
[2] F. Ducray,et al. Devic’s syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[3] A. Saiz,et al. Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies , 2007, Journal of Neurology.
[4] R. Sheorajpanday,et al. Small cell lung carcinoma presenting as collapsin response-mediating protein (CRMP) -5 paraneoplastic optic neuropathy. , 2006, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[5] P. C. Calvert. A CR(I)MP in the optic nerve: recognition and implications of paraneoplastic optic neuropathy. , 2006, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[6] J. Dalmau,et al. Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment. , 2004, Seminars in neurology.
[7] V. Lennon,et al. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome , 2004, Annals of neurology.
[8] A. Samii,et al. Paraneoplastic movement disorder in a patient with non‐Hodgkin's lymphoma and CRMP‐5 autoantibody , 2003, Movement disorders : official journal of the Movement Disorder Society.
[9] J. Parisi,et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP‐5‐IgG , 2003, Annals of neurology.
[10] C. Adler,et al. Paraneoplastic chorea associated with CRMP‐5 neuronal antibody and lung carcinoma , 2002, Annals of neurology.
[11] N. Newman,et al. Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung. , 2001, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[12] E. Benarroch,et al. CRMP‐5 neuronal autoantibody: Marker of lung cancer and thymoma‐related autoimmunity , 2001, Annals of neurology.
[13] J. Honnorat,et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone , 2000, Journal of neurology, neurosurgery, and psychiatry.
[14] J. Guy,et al. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. , 1999, Archives of ophthalmology.
[15] J. Keltner,et al. Paraneoplastic Optic Neuropathy and Autoantibody Production in Small‐Cell Carcinoma of the Lung , 1998, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[16] C. Thirkill,et al. Paraneoplastic Retinopathy: A Novel Autoantibody Reaction Associated with Small‐cell Lung Carcinoma , 1997, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[17] H. Sugihara,et al. Autopsy report of acute necrotizing opticomyelopathy associated with thyroid cancer , 1993, Journal of the Neurological Sciences.
[18] A. Furlan,et al. Optic neuropathy: a rare paraneoplastic syndrome. , 1992, Journal of clinical neuro-ophthalmology.
[19] A. Roth,et al. Management and monitoring of cancer-associated retinopathy. , 1992, Archives of ophthalmology.
[20] T. Hoogenraad,et al. Paraneoplastic optic neuropathy with histopathological verification of absence of meningeal metastases , 1989 .